Bio-IT World Keynote Highlights Collaborative Intelligence in AI-Driven Drug Discovery
Bio-IT World Keynote Highlights Collaborative Intelligence in AI-Driven Drug Discovery
Publish Date: 2026-06-01 16:15:00
Source Domain: www.genengnews.com
- The Bio-IT World Conference 2026 keynote panel discussed foundation models and federated learning’s role in AI’s advancement in drug discovery.
- The importance of open-source platforms like the AI Structural Biology (AISB) initiative was highlighted, which uses pooled data to train models like OpenFold3.
- Federated learning was presented as a secure way to utilize proprietary biopharma data without compromising on privacy.
- Eli Lilly’s TuneLab was showcased as a successful federated learning implementation facilitating community improvement of AI models.
- Challenges involved in industrial federated learning setups like data preparation without centralization were discussed.
- SandboxAQ emphasized the significance of fine-tuning models with project-specific data for practical drug discovery impact.
- Bayer’s use of foundational AI models for fast advancement in crop science and pharmaceutical traits was highlighted.
